STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO
· statnews.com · popularity 32/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at statnews.com →
Summary
A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 8.